KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Assets Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.47%
Dec 31, 2025 -1.18%
Sep 30, 2025 -1.78%
Jun 30, 2025 -1.42%
Mar 31, 2025 -1.67%
Dec 31, 2024 -2.66%
Sep 30, 2024 -1.23%
Jun 30, 2024 -1.38%
Mar 31, 2024 -0.36%
Dec 31, 2023 -3.64%
Sep 30, 2023 -3.08%
Jun 30, 2023 -3.26%
Mar 31, 2023 13.84%
Dec 31, 2022 15.92%
Sep 30, 2022 33.47%
Jun 30, 2022 35.83%
Mar 31, 2022 36.13%
Dec 31, 2021 35.15%
Sep 30, 2021 31.03%
Jun 30, 2021 33.90%
Mar 31, 2021 29.47%
Dec 31, 2020 28.61%
Sep 30, 2020 29.53%
Jun 30, 2020 30.69%
Mar 31, 2020 11.57%
Dec 31, 2019 10.47%
Sep 30, 2019 -3.73%
Jun 30, 2019 -5.27%
Mar 31, 2019 1.86%
Dec 31, 2018 3.81%
Sep 30, 2018 6.46%
Jun 30, 2018 4.60%
Mar 31, 2018 37.46%
Dec 31, 2017 37.03%
Sep 30, 2017 34.25%
Jun 30, 2017 32.13%
Mar 31, 2017 31.84%
Dec 31, 2016 31.30%
Sep 30, 2016 33.11%
Jun 30, 2016 34.04%
Mar 31, 2016 25.51%
Dec 31, 2015 25.24%